Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease

Neuroscience Letters

Volumn 271, Issue 2, 1999, Pages 132-134

  Shibata, Nobuto ^a   Ohnuma, Tohru ^a   Takahashi, Tadashi ^a   Ohtsuka, Emiko ^b   Ueki, Akira ^b   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Jichi Medical University   (Japan)

Author keywords

Alpha 2 macroglobulin genetic polymorphism; Alzheimer's disease; Sporadic

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; PROTEINASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; JAPAN; MALE; POLYMORPHISM, GENETIC;

EID: 0033588361     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00541-8     Document Type: Article

References (12)

1. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go Rodney C.P., Perry R., Watson Jr B., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:1998;357-360.
2. Borth W. Alpha-2-macroglobulin, a multi-functional binding protein with targeting characteristics. FASEB J. 6:1992;3345-3353.
3. Dow D.J., Lindsey N., Cairns N.J., Brayne C., Robinson D., Huppert F.A., Paykel E.S., Xuereb J., Wilcock G., Whittaker J.L., Rubinsztein D.C. α-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat. Genet. 22:1999;16-17.
4. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Heroux J., Riedel N.G., Sahasrabudhe S. Alpha-2-macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA. 95:1998;3275-3280.
5. Matthijs G., Marynen P. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nucl. Acids Res. 19:1991;5102.
6. Pericak-Vance M.A., Bass M.L., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer's disease. Neurobiol., Aging. 19:1998;39-42.
7. Qiu W.Q., Borth W., Ye Z., Haass C., Teplow D., Selkoe D.J. Degradation of amyloid beta protein by a serine proteinase alpha-2-macroglobulin complex. J. Biol. Chem. 271:1996;8443-8451.
8. Rebeck W.G., Harr S.D., Strickland D.K., Hyman B.T. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37:1995;211-217.
9. Rogaeva E.A., Premkumar S., Grubber J., Serneels L., Scott W.K., Kawarai T., Song Y., Hill D.L., Abou-Donia S.M., Martin E.R., Vance J.J., Yu G., Orlacchio A., Pei Y., Nishimura M., Supala A., Roberge B., Saunders A.M., Roses A.D., Schmechel D., Crane-Gatherum A., Sorbi S., Bruni A., Small G.W., Conneally P.M., Haines J.L., Leuven F.V., St. George-Hyslop P.H., Farrer L.A., Pericak-Vance M.A. An α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat. Genet. 22:1999;19-21.
10. Rudrasingham V., Vrieze F.W., Lambert J-C., Chakravently S., Kehoe P., Crook R., Amouyel P., Wu W., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Petersen R., Cottel D., Tunstall N., Holmans P., Lovestone S., Chartier-Harlin M-C., Goate A., Hardy J., Owen M.J., Williams J. α-2 macroglobulin gene and Alzheimer disease. Nat. Genet. 22:1999;17-19.
11. Scott W.K., Growdon J.H., Roses A.D., Haines J.L., Pericak-Vance M.A. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1186-1187.
12. Wragg, M., Hutton, M., Talbot, C. and The Alzheimer's Disease Collaborative Group, Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet, 347 (1996) 509-512.